TrialBreast cancer research and treatment2025

Assessing racial disparities in disease outcomes of patients with high-risk, triple-negative breast cancer and residual disease after neoadjuvant therapy: a post-hoc analysis of the ECOG-ACRIN 1131 clinical trial.

Kate Lloyd et al.PubMed ↗Publisher ↗

No numbers read from the abstract.